Fundz

Gro Biosciences Announces $25M Series A Financing Led By Leaps By Bayer And Redmile Group

PRIVATENov 03, 2021

Amount Raised

$25 Million

Round Type

Series A

CambridgeBiotechnologyHealth CareTherapeutics

Description

GRO Biosciences Inc. (“GRObio”), an emerging biotechnology company leveraging groundbreaking science to expand the amino acid alphabet and deliver on the promise of protein therapeutics, today announced the closing of a Series A financing totaling $25 million co-led by Leaps by Bayer and Redmile Group. The financing was joined by lead seed investors Digitalis Ventures, Innovation Endeavors and others bringing the total investment to $31.2 million.

Quick answer

GRO Biosciences raised $25 Million in a Series A round, dated November 3, 2021. GRO Biosciences is based in Cambridge, Massachusetts, United States.

How much did GRO Biosciences raise?
GRO Biosciences raised $25 Million in a Series A round on November 3, 2021.
What does GRO Biosciences do?
GRO Biosciences is an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics.
Where is GRO Biosciences based and how big is it?
GRO Biosciences is based in Cambridge, Massachusetts, United States.
Who are the decision-makers at GRO Biosciences?
Fundz holds 1 contact at GRO Biosciences. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who to call at GRO Biosciences, and when

A new round usually means GRO Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GRO Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GRO Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GRO Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GRO Biosciences

Location

Cambridge, Massachusetts, United States

About

GRO Biosciences is an emerging biotechnology company leveraging synthetic biology to expand the amino acid alphabet and deliver on the promise of protein therapeutics. The company is transforming treatments in diverse areas including autoimmune and metabolic diseases to improve the lives of patients. GRO Biosciences is applying its platform to advance partnered and collaborative programs, as well as its own pipeline of protein therapeutics bearing unique non-standard amino acid (NSAA) chemistries.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GRO Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for GRO Biosciences's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

GRO Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.